ArticleBiomaterials science2025
Image-guided embolization using Ta@Ca-Alg microspheres with optimized mechanical performance.
Article in Biomaterials science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Therapeutic embolic agents for targeted drug delivery in transcatheter therapies: a review.Chemical communications (Cambridge, England) · 2026Review
- Porosity optimization confers 3D-printed porous tantalum scaffolds with superior osteogenic capability and biocompatibility over titanium alloys.Journal of orthopaedic surgery and research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Transcatheter arterial embolization (TAE) is a minimally invasive technique used to treat hypervascular tumors, hemorrhage, and vascular abnormalities. Though microspheres (MSs) have achieved widespread clinical use as embolic agents, they often lack imaging opacity, optimal morphology and mechanical properties which can lead to unpredictable trajectories, non-target delivery, and suboptimal embolization. This study developed tantalum-loaded calcium alginate (Ta@Ca-Alg) MSs with intrinsic radiopacity, tunable density, and mechanical properties. Ta@Ca-Alg MSs were synthesized using a gas-shearing method and analyzed for size, morphology, swelling behavior, density, radiopacity, and optimized mechanical properties. The results demonstrated that Ta@Ca-Alg MSs maintained a narrow size distribution, with increasing Ta concentration enhancing radiopacity to levels comparable with the clinical contrast agent OMNIPAQUE 350. Density and Young's modulus corresponding to different Ta concentrations were also investigated. Phantom model testing validated effective vessel occlusion and controlled penetration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.